Bevespi Aerosphere treats COPD including chronic bronchitis and/or emphysema.
Bevespi Aerosphere Overview
Bevespi Aerosphere is a prescription medication used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Bevespi Aerosphere is a single product containing 2 products:glycopyrrolate and formoterol fumarate.
Glycopyrrolate belongs to a group of drugs called anticholinergics. Formoterol fumarate belongs to a group of drugs called long-acting beta agonists (LABAs). Together these work to make it easier to breathe, because they help relax the muscles around the airways in your lungs.
This medication is available as an inhalation and is typically used twice a day.
Common side effects of Bevespi Aerosphere include urinary tract infection and cough.
Patient Ratings for
How was your experience with ?
Bevespi Aerosphere Drug Class
Bevespi Aerosphere is part of the drug class: